Thyroid cancer in the age of COVID-19

COVID-19 has modified the way we practice medicine. For thyroid cancer, there have been several significant impacts. First, the diagnosis has been delayed due to social isolation, reduced access to investigations and staff redeployment. Secondly, treatment planning has needed to take into account th...

Full description

Saved in:
Bibliographic Details
Published inEndocrine-related cancer Vol. 27; no. 11; pp. R407 - R416
Main Authors Tsang, Venessa H M, Gild, Matti, Glover, Anthony, Clifton-Bligh, Roderick, Robinson, Bruce G
Format Journal Article
LanguageEnglish
Published England Bioscientifica Ltd 01.11.2020
Society for Endocrinology & BioScientifica Ltd
Subjects
Betacoronavirus
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Delayed Diagnosis
Disease transmission
Hospitals
Humans
Iodine Radioisotopes - therapeutic use
Pandemics
Pneumonia, Viral - epidemiology
Protein Kinase Inhibitors - therapeutic use
Review
SARS-CoV-2
Social interactions
Thyroid cancer
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - therapy
COVID-19
radioactive iodine
thyroid cancer
tyrosine kinase inhibitor
Online AccessGet full text

Cover

Abstract COVID-19 has modified the way we practice medicine. For thyroid cancer, there have been several significant impacts. First, the diagnosis has been delayed due to social isolation, reduced access to investigations and staff redeployment. Secondly, treatment planning has needed to take into account the risk to patients and/or staff of nosocomial transmission of the virus. Finally, there are some specific concerns with respect to interactions between the virus, its treatments and cancer. This mini-review aims to address each of these impacts and to provide some guidance and confidence to our patients and colleagues during this challenging time.
AbstractList COVID-19 has modified the way we practice medicine. For thyroid cancer, there have been several significant impacts. First, the diagnosis has been delayed due to social isolation, reduced access to investigations and staff redeployment. Secondly, treatment planning has needed to take into account the risk to patients and/or staff of nosocomial transmission of the virus. Finally, there are some specific concerns with respect to interactions between the virus, its treatments and cancer. This mini-review aims to address each of these impacts and to provide some guidance and confidence to our patients and colleagues during this challenging time.
Author Clifton-Bligh, Roderick
Tsang, Venessa H M
Gild, Matti
Glover, Anthony
Robinson, Bruce G
AuthorAffiliation Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia
Department of Endocrine Surgery, Royal North Shore Hospital, St Leonards, Sydney, Australia
AuthorAffiliation_xml – name: Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia
– name: Department of Endocrinology, Royal North Shore Hospital, St Leonards, Sydney, Australia
– name: Department of Endocrine Surgery, Royal North Shore Hospital, St Leonards, Sydney, Australia
– name: Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
Author_xml – sequence: 1
  givenname: Venessa H M
  surname: Tsang
  fullname: Tsang, Venessa H M
  email: venessa.tsang@sydney.edu.au
  organization: Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia
– sequence: 2
  givenname: Matti
  surname: Gild
  fullname: Gild, Matti
  organization: Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia
– sequence: 3
  givenname: Anthony
  surname: Glover
  fullname: Glover, Anthony
  organization: Department of Endocrine Surgery, Royal North Shore Hospital, St Leonards, Sydney, Australia
– sequence: 4
  givenname: Roderick
  surname: Clifton-Bligh
  fullname: Clifton-Bligh, Roderick
  organization: Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia
– sequence: 5
  givenname: Bruce G
  surname: Robinson
  fullname: Robinson, Bruce G
  organization: Cancer Genetics Laboratory, Kolling Institute of Medical Research, Sydney, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32810844$$D View this record in MEDLINE/PubMed
BookMark eNp90M1LwzAcxvEginvRk3cpiCBINK9NcpQ6dTAYyPAa2jR1GVszk_aw_96MTQ8ePCWHDw8_viNw2vrWAnCF0QPmFD1O3gtIEEREqBMwxEwomEuCT9OfcgwRknIARjGuEEK55PwcDCiRGEnGhuB2sdwF7-rMlK2xIXNt1i1tVn7azDdZMf-YPkOsLsBZU66jvTy-Y7B4mSyKNzibv06LpxmsqMo7yHKKlbKI5SZHyggi8pLWglVUKEUpMqRRwgghSWWUwoZVTRJ1gyvFDVV0DO4Os9vgv3obO71x0dj1umyt76MmjHJOpCQy0Zs_dOX70KbjkhKUMUo5Ser-oEzwMQbb6G1wmzLsNEZ6H0-neJogvY-X9PVxs682tv61P7USwAdQOR-Ns23nGmfKf0e_AYV-dlQ
CitedBy_id crossref_primary_10_17826_cumj_1152618
crossref_primary_10_1136_bmjopen_2022_069236
crossref_primary_10_1007_s11154_020_09615_z
crossref_primary_10_2217_fon_2021_0585
crossref_primary_10_1111_cen_14486
crossref_primary_10_3390_cancers15113032
crossref_primary_10_1210_jendso_bvab076
crossref_primary_10_3389_fendo_2023_1221795
crossref_primary_10_1177_03008916211007927
crossref_primary_10_1245_s10434_021_10101_2
crossref_primary_10_22270_jddt_v11i2_S_4664
crossref_primary_10_3390_jcm10132920
crossref_primary_10_3390_curroncol31060263
crossref_primary_10_1515_iss_2022_0015
crossref_primary_10_3390_diagnostics14020166
crossref_primary_10_1007_s12020_020_02559_z
crossref_primary_10_3390_cancers14174338
crossref_primary_10_1016_j_surg_2022_06_043
crossref_primary_10_22159_ijap_2023v15i5_47937
crossref_primary_10_3390_cancers13030371
crossref_primary_10_3390_diseases12030062
crossref_primary_10_1007_s13304_024_01771_0
crossref_primary_10_1007_s40618_021_01641_1
crossref_primary_10_1016_j_eprac_2022_01_002
crossref_primary_10_7197_cmj_1118859
crossref_primary_10_1111_ans_18253
crossref_primary_10_1007_s40618_021_01554_z
crossref_primary_10_1210_clinem_dgad163
crossref_primary_10_2147_IJGM_S339998
ContentType Journal Article
Copyright 2020 Society for Endocrinology
Copyright Society for Endocrinology & BioScientifica Ltd. Nov 2020
Copyright_xml – notice: 2020 Society for Endocrinology
– notice: Copyright Society for Endocrinology & BioScientifica Ltd. Nov 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TO
H94
7X8
DOI 10.1530/ERC-20-0279
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Oncogenes and Growth Factors Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
Oncogenes and Growth Factors Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Thyroid cancer during COVID-19
EISSN 1479-6821
EndPage R416
ExternalDocumentID 10_1530_ERC_20_0279
32810844
Genre Journal Article
Review
GroupedDBID -
0R
0VX
2WC
4.4
53G
5GY
5VS
AAFZV
AAPBV
ABLYK
ABOCM
ABPTK
ABSGY
ABSQV
ADACO
ADBBV
ADDZX
AENEX
AGCAB
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HZ
IL9
INIJC
KQ8
O0-
O9-
OK1
P2P
REN
RHF
TBS
TR2
UDS
WOQ
---
0R~
18M
ACGFO
AFHIN
CGR
CUY
CVF
ECM
EIF
F9R
HZ~
NPM
W8F
AAYXX
CITATION
7TO
H94
7X8
ID FETCH-LOGICAL-b396t-463199e046c609c7276a3d74b3799330c2f97c7782bc991c4bf76adf1b95c393
ISSN 1351-0088
IngestDate Fri Jun 28 04:59:40 EDT 2024
Thu Oct 10 15:49:04 EDT 2024
Fri Dec 06 04:22:58 EST 2024
Sat Sep 28 08:26:52 EDT 2024
Wed Apr 14 02:20:57 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords COVID-19
radioactive iodine
thyroid cancer
tyrosine kinase inhibitor
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b396t-463199e046c609c7276a3d74b3799330c2f97c7782bc991c4bf76adf1b95c393
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink http://dx.doi.org/10.1530/ERC-20-0279
PMID 32810844
PQID 2473443352
PQPubID 2048752
ParticipantIDs proquest_miscellaneous_2435528828
proquest_journals_2473443352
crossref_primary_10_1530_ERC_20_0279
pubmed_primary_32810844
bioscientifica_primary_10_1530_ERC_20_0279
PublicationCentury 2000
PublicationDate 20201100
2020-11-00
20201101
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 20201100
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Bristol
PublicationTitle Endocrine-related cancer
PublicationTitleAlternate Endocr Relat Cancer
PublicationYear 2020
Publisher Bioscientifica Ltd
Society for Endocrinology & BioScientifica Ltd
Publisher_xml – name: Bioscientifica Ltd
– name: Society for Endocrinology & BioScientifica Ltd
SSID ssj0006855
Score 2.5017726
SecondaryResourceType review_article
Snippet COVID-19 has modified the way we practice medicine. For thyroid cancer, there have been several significant impacts. First, the diagnosis has been delayed due...
SourceID proquest
crossref
pubmed
bioscientifica
SourceType Aggregation Database
Index Database
Publisher
StartPage R407
SubjectTerms Betacoronavirus
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Delayed Diagnosis
Disease transmission
Hospitals
Humans
Iodine Radioisotopes - therapeutic use
Pandemics
Pneumonia, Viral - epidemiology
Protein Kinase Inhibitors - therapeutic use
Review
SARS-CoV-2
Social interactions
Thyroid cancer
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - therapy
Title Thyroid cancer in the age of COVID-19
URI http://dx.doi.org/10.1530/ERC-20-0279
https://www.ncbi.nlm.nih.gov/pubmed/32810844
https://www.proquest.com/docview/2473443352
https://search.proquest.com/docview/2435528828
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELagSAgkEHe3LShI5QWUksRH4ke63bKFHtIqrfbNih1HilQl1Xb7AL-ecXxsKYcKL1HkdZzNfPZ4ZuzPg9A2uCRSEg0DSVMWE56BHqxgXBHa0KSm0MMSQxQ-OmbTU_JlTuc-vbtjlyzljvr-W17J_6AKZYCrYcn-A7KhUSiAe8AXroAwXG-J8bdF39Zm55bSC79lsbJxgPHJ2cFe7DSFj713da8M3y8eOCzaPxr890sXPj4bVGD1YbqKln5ubQzZZAhvQ2HYAupOIQhrGudtY7IT7563dhVnZpKu-SP4XZgBfMo0hBm0VY0k5zErLJ_Z607L6_d9JL2mCWfEZrN1s-qMWErlLxobugOIeTIbA7JmQZmvJia_GH98IvZPDw9FOZmXd9E9c-ShyZKwd_A1zLmsoNSxL6HBj9eae4geydaeCzpsvrphgPzBqxisi_IJeuzcguiTxfgpuqO7Z-j-kdv48By9c1BHFq-o7SKAOoJvjvom8lC_QOX-pBxPY5fhIpaYs2VMGGhArhPCFEu4AluSVbjOicQ5N5EmlTU8VzlYcVKBIa-IbKBG3aSSU4U5fonWur7T6yiqZZbiWskGg71BGWjZpGIFoykmxkYhI_T-ZzGIC3uaiTBeIMhMgMxElggjsxHa9iL6e7UtLz7hRsWlyEiOCTFMvhF6G34GnWUWoqpO91emDli5Gfh2xQi9smIP74H_nyYFIRu3eHoTPVh11S20tlxc6ddgIy7lm6F7_ADr9mB_
link.rule.ids 314,780,784,27924,27925
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thyroid+cancer+in+the+age+of+COVID-19&rft.jtitle=Endocrine-related+cancer&rft.au=Tsang%2C+Venessa+H+M&rft.au=Gild%2C+Matti&rft.au=Glover%2C+Anthony&rft.au=Clifton-Bligh%2C+Roderick&rft.date=2020-11-01&rft.eissn=1479-6821&rft.volume=27&rft.issue=11&rft.spage=R407&rft.epage=R416&rft_id=info:doi/10.1530%2FERC-20-0279&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-0088&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-0088&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-0088&client=summon